Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii and Stenotrophomonas maltophilia: a …

S Karakonstantis, M Rousaki, L Vassilopoulou… - Clinical Microbiology …, 2023 - Elsevier
Background Cefiderocol is a last resort option for carbapenem-resistant (CR) Gram-negative
bacteria, especially metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa and …

Ceftazidime-avibactam and aztreonam combination for Carbapenem-resistant Enterobacterales bloodstream infections with presumed Metallo-β-lactamase …

N Gupta, C Boodman, P Prayag… - Expert Review of Anti …, 2024 - Taylor & Francis
ABSTRACT Introduction Carbapenem-resistant Enterobacterales (CRE) due to Metallo-β-
lactamase (MBL) production are treated with either polymyxins or the novel combination of …

Indian consensus on the managemeNt of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II)

R Soman, B Veeraraghavan, A Hegde… - Expert Review of Anti …, 2024 - Taylor & Francis
Introduction The rising challenge of carbapenem-resistant Enterobacterales (CRE)
infections in Indian healthcare settings calls for clear clinical guidance on the management …

Antimicrobial Susceptibilities of Clinical Bacterial Isolates from Urinary Tract Infections to Fosfomycin and Comparator Antibiotics Determined by Agar Dilution Method …

JL Dombach, N Smith, T Kottiri, AM Schiller, E Kamau - medRxiv, 2024 - medrxiv.org
Uncomplicated bacteremic urinary tract infections (bUTIs) are common, often caused by
Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecalis, with most encounters …